Chorionic Villus Sampling (CVS): What It Is, What It Tells You, and What Shapes the Experience
Chorionic villus sampling — commonly called CVS — is a prenatal diagnostic procedure, not a wellness practice or supplement. It involves removing a small sample of placental tissue during pregnancy to test fetal chromosomes and genetic material. It belongs to the category of medical diagnostics, performed by trained obstetricians and maternal-fetal medicine specialists under ultrasound guidance.
This article explains what CVS is, what information it provides, and the factors that shape how the procedure and its results are experienced — because the decision to pursue it, and what to do with the results, looks different for every pregnant person.
What CVS Actually Is
CVS is a diagnostic test, not a screening test. That distinction matters.
- Screening tests (like cell-free DNA tests or first-trimester blood panels) estimate the probability that a chromosomal condition is present
- Diagnostic tests like CVS provide a definitive answer about whether certain chromosomal or genetic conditions are present in fetal cells
The procedure is typically performed between 10 and 13 weeks of pregnancy — earlier than amniocentesis, which is usually done around 15–20 weeks. A small sample of chorionic villi (tiny finger-like projections of placental tissue that share the fetal genetic makeup) is collected either through the cervix (transcervically) or through the abdominal wall (transabdominally), depending on placental position and individual anatomy.
Because placental cells share the same genetic origin as fetal cells, the sample can be analyzed for chromosomal abnormalities — including Down syndrome (trisomy 21), trisomy 18, trisomy 13 — as well as single-gene disorders like cystic fibrosis, sickle cell disease, Tay-Sachs disease, and others, when there is a known family history or carrier status.
What CVS Can and Cannot Tell You 🔬
CVS can detect:
- Chromosomal conditions (aneuploidies) with a high degree of accuracy
- Specific inherited genetic disorders when testing is targeted to known mutations
- Some chromosomal structural abnormalities
CVS cannot detect:
- Neural tube defects (such as spina bifida) — these require a follow-up AFP blood test or detailed ultrasound
- All possible genetic mutations — only those specifically tested
- Conditions caused by environmental or developmental factors unrelated to chromosomes
It's also worth knowing that CVS results occasionally show findings called confined placental mosaicism — where chromosomal differences appear in the placental cells but are not present in the fetus itself. This can lead to results that require further testing or interpretation by a genetic counselor.
Who Typically Considers CVS
CVS is not a routine test offered to all pregnant people. It is generally considered when:
- A screening test has returned a high-probability result for a chromosomal condition
- A parent is a known carrier of a specific genetic disorder
- There is a family history of a chromosomal or single-gene condition
- A previous pregnancy was affected by a genetic condition
- Maternal age or other factors raise clinical concern
The earlier timing of CVS (compared to amniocentesis) can matter significantly to those who want diagnostic information in the first trimester — whether for personal, medical, or reproductive decision-making reasons.
The Risk Factor Most People Ask About
CVS carries a small risk of pregnancy loss. Published estimates vary across studies, but procedural pregnancy loss rates are generally cited in the range of approximately 0.5% to 1%, with some more recent research suggesting rates closer to those of amniocentesis when performed by experienced providers. Factors that affect risk include:
- Provider experience and procedural volume
- Technique used (transcervical vs. transabdominal)
- Placental position and individual anatomy
- Gestational age at the time of the procedure
No risk figure is universal. The specific numbers in any individual case depend on the clinical circumstances and who is performing the procedure.
How Results Are Processed and What Shapes the Experience 🧬
Results from CVS typically come back within 1 to 2 weeks for full chromosomal analysis, though some preliminary FISH (fluorescence in situ hybridization) results may be available sooner for common aneuploidies.
What someone does with those results — and how they experience receiving them — depends on a range of deeply personal, medical, and ethical factors:
| Factor | Why It Shapes the Experience |
|---|---|
| Reason for testing | Carrier status vs. screening result vs. family history changes what's expected |
| Access to genetic counseling | Affects how results are understood and contextualized |
| Support systems | Emotional and practical support influences decision-making capacity |
| Personal and cultural values | Shape how genetic information is interpreted and acted upon |
| Healthcare access | Affects what options are available after a result |
Where the Individual Picture Becomes Essential
CVS is a medical procedure ordered and performed within a clinical context — meaning how it applies to any specific pregnancy depends on the full picture: gestational age, placental location, personal and family genetic history, existing screening results, and the goals of the individual or couple involved.
The information a CVS result provides can be definitive about certain chromosomal questions — but what that information means for a given pregnancy, and what steps follow, is something that unfolds differently for each person involved.
